LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine

Takeda penned a potentially billion-dollar deal with Anima Biotech to work on mRNA translation modulators for neurological diseases. The Japanese pharma als

AbbVie to Develop mRNA Modulators Using Anima Biotech Platform

Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines

Daiichi Sankyo to establish Japan's first mRNA production facility

BioSpectrum Asia Jan 2023 - Flip eBook Pages 1-50

Anima Biotech - mRNA Lightning Platform

AZ-Daiichi, Moderna, Takeda and more—Fierce Pharma Asia

Press Releases - Media - Daiichi Sankyo

Japan approves first domestically developed COVID-19 XBB vaccine - The Japan Times

PharmaCompass – Grow Your Pharma Business Digitally

AbbVie, Anima Strike mRNA Deal Worth Up to $582M

Collection of Healthcare News and Biomedical Development — Mar. and April 2021, by Willies Wu

Anima Biotech - Company info. interviews, news

Press Releases - Media - Daiichi Sankyo

Sponsor Detail Template – Chinese American Biopharmaceutical Society